Qiang Li Selected Research

jasmone

12/2020

CsPrx25, a class III peroxidase in Citrus sinensis, confers resistance to citrus bacterial canker through the maintenance of ROS homeostasis and cell wall lignification.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiang Li Research Topics

Disease

401	Neoplasms (Cancer) 07/2022 - 04/2002
107	Inflammation (Inflammations) 04/2022 - 07/2003
80	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 02/2006
73	Neoplasm Metastasis (Metastasis) 06/2022 - 06/2005
73	Infections 04/2022 - 01/2003
64	Type 2 Diabetes Mellitus (MODY) 01/2022 - 08/2005
53	Lung Neoplasms (Lung Cancer) 01/2022 - 04/2002
51	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 02/2003
48	Hypertension (High Blood Pressure) 09/2022 - 07/2007
47	Hypoxia (Hypoxemia) 06/2022 - 01/2003
46	Carcinogenesis 01/2022 - 09/2007
38	Stomach Neoplasms (Stomach Cancer) 03/2022 - 01/2006
38	Wounds and Injuries (Trauma) 02/2020 - 01/2003
37	Breast Neoplasms (Breast Cancer) 03/2022 - 04/2006
37	Fibrosis (Cirrhosis) 01/2022 - 01/2012
36	Carcinoma (Carcinomatosis) 05/2022 - 10/2003
33	COVID-19 03/2022 - 01/2020
33	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 12/2008
31	Aneurysm (Aneurysms) 09/2022 - 02/2009
30	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 11/2008
28	Insulin Resistance 01/2022 - 05/2007
27	Stroke (Strokes) 01/2022 - 11/2009
25	Pain (Aches) 01/2022 - 11/2010
25	Obesity 01/2022 - 05/2007
24	Ischemic Stroke 11/2022 - 02/2014
24	Body Weight (Weight, Body) 04/2022 - 03/2010
23	Pancreatic Neoplasms (Pancreatic Cancer) 06/2022 - 05/2007
21	Thrombosis (Thrombus) 01/2022 - 06/2010
21	Chronic Hepatitis B 05/2021 - 06/2007
20	Necrosis 03/2022 - 01/2007
19	Acute Lung Injury 03/2022 - 01/2010
19	Myocardial Infarction 02/2022 - 12/2008
19	Non-alcoholic Fatty Liver Disease 01/2022 - 04/2011
19	Chronic Renal Insufficiency 01/2022 - 04/2017
17	Pathologic Constriction (Stenosis) 09/2022 - 12/2005
17	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 08/2008
16	Melanoma (Melanoma, Malignant) 06/2022 - 02/2007
16	Tuberculosis (Tuberculoses) 04/2022 - 12/2005
16	Hemorrhage 02/2022 - 01/2014
16	Pneumonia (Pneumonitis) 01/2022 - 05/2006
16	Vascular Diseases (Vascular Disease) 01/2022 - 11/2010
16	Diabetes Mellitus 12/2021 - 01/2010
16	Infarction (Infarctions) 05/2021 - 01/2011
15	Alzheimer Disease (Alzheimer's Disease) 08/2022 - 12/2012
15	Glioma (Gliomas) 07/2022 - 01/2004
15	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 07/2011
15	Heroin Dependence (Heroin Abuse) 01/2022 - 09/2010
15	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 03/2008
15	Brain Injuries (Brain Injury) 01/2020 - 08/2013
14	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 11/2007
14	Ischemia 01/2022 - 03/2004
13	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 12/2022 - 02/2015
13	Adenocarcinoma of Lung 05/2022 - 11/2002

Drug/Important Bio-Agent (IBA)

157	Proteins (Proteins, Gene)FDA Link 06/2022 - 02/2003
78	Biomarkers (Surrogate Marker)IBA 10/2022 - 03/2003
70	Pharmaceutical PreparationsIBA 08/2022 - 08/2004
61	Messenger RNA (mRNA)IBA 04/2022 - 07/2008
61	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 01/2006
58	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2010
57	CytokinesIBA 01/2022 - 11/2004
48	Biological ProductsIBA 04/2022 - 09/2007
37	Long Noncoding RNAIBA 03/2022 - 01/2015
35	Therapeutic UsesIBA 06/2022 - 01/2004
33	LipidsIBA 04/2022 - 05/2007
31	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 06/2002
29	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2022 - 03/2004
28	EnzymesIBA 04/2022 - 11/2004
26	RNA (Ribonucleic Acid)IBA 01/2022 - 02/2006
24	Small Interfering RNA (siRNA)IBA 03/2022 - 12/2007
24	Insulin (Novolin)FDA Link 02/2022 - 01/2009
24	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 02/2006
24	CarbonIBA 01/2022 - 08/2007
20	Circular RNAIBA 07/2022 - 01/2018
20	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 11/2002
20	Interleukin-6 (Interleukin 6)IBA 01/2022 - 11/2004
19	AntioxidantsIBA 01/2022 - 03/2005
18	CalciumIBA 01/2022 - 01/2003
16	PlatinumIBA 05/2022 - 07/2012
16	LipopolysaccharidesIBA 03/2022 - 10/2006
16	Phosphotransferases (Kinase)IBA 02/2022 - 11/2011
16	Transcription Factors (Transcription Factor)IBA 02/2022 - 01/2003
16	Alanine Transaminase (SGPT)IBA 11/2021 - 11/2007
16	Interleukin-10 (Interleukin 10)IBA 03/2021 - 03/2009
16	Gliclazide (Diamicron)IBA 01/2018 - 11/2010
15	Polysaccharides (Glycans)IBA 08/2022 - 03/2012
15	IonsIBA 01/2022 - 07/2008
15	perindopril drug combination indapamideIBA 01/2018 - 11/2010
14	C-Reactive ProteinIBA 01/2022 - 07/2010
14	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2004
14	Peptides (Polypeptides)IBA 01/2022 - 10/2009
13	AlbuminsIBA 01/2022 - 11/2007

Therapy/Procedure

187	Therapeutics 07/2022 - 03/2002
65	Drug Therapy (Chemotherapy) 06/2022 - 03/2002
56	Stents 11/2022 - 06/2004
33	Radiotherapy 06/2022 - 06/2004
22	Length of Stay 02/2022 - 06/2007
18	Immunotherapy 05/2022 - 03/2006
18	Transplantation 01/2022 - 09/2005
14	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2022 - 06/2009
14	Percutaneous Coronary Intervention 01/2022 - 12/2008